BCL2 and colorectal cancer: In several studies over-expression (Cyclin D1, NF-κB, PCNA, MMP-2) or loss of expression (Bcl-2, APC) of these molecules have been found to be associated with more aggressive tumor growth in colorectal cancer [17], [38]–[40].